Seasoned venture capitalist, a senior executive at Intel and pre-IPO technology companies, a World Bank economist, and a faculty at UC Berkeley with more than 20 years of experience in the high-tech industry.
As a venture investor, Ms. Kline co-founded a venture capital fund investing in early-stage technology companies in Latin America, where she invested in notable impact-minded companies. She also served as a partner at a venture fund investing in early-stage high-growth companies across the US and Canada. Recently, she founded SeaSky Lab an organization that brings knowledge and resources for tech entrepreneurs from Silicon Valley to Asia. As an operating executive, Ms. Kline was the President of AHEAD Medicine – a life science company using machine learning for cell analysis – holding six global IPs. Prior to AHEAD Medicine, she was a senior executive at Intel Corp., where she pioneered, launched, and scaled the company’s first Android-based tablet device globally. Ms. Kline was also an economist at The World Bank Group, where she supported Ministries of Finance in emerging markets to implement technology development projects in South America, Africa, Asia, and Eastern Europe. Ms. Kline is one of the first Thai women selected to lecture a popular MBA course Impact Venture Capital Investing – Sustainable & Impact Finance Curriculum – at the Haas School of Business, UC Berkeley. She also serves Berkeley Skydeck, a top accelerator program, as an investor and Global Ambassador to 48 countries in the Asia-Pacific region. Her board work includes AHEAD Medicine (biotech), The Circulate Initiative by Circulate Capital (climate tech), Dietz Co. (health tech), and Intel Alumni Network (global tech executives). She is also an advisor to selected founders/CEOs at The Alchemist Accelerator and UCSF Health Hub Incubation in the San Francisco Bay Area.
As a venture investor, Ms. Kline co-founded a venture capital fund investing in early-stage technology companies in Latin America, where she invested in notable impact-minded companies. She also served as a partner at a venture fund investing in early-stage high-growth companies across the US and Canada. Recently, she founded SeaSky Lab an organization that brings knowledge and resources for tech entrepreneurs from Silicon Valley to Asia. As an operating executive, Ms. Kline was the President of AHEAD Medicine – a life science company using machine learning for cell analysis – holding six global IPs. Prior to AHEAD Medicine, she was a senior executive at Intel Corp., where she pioneered, launched, and scaled the company’s first Android-based tablet device globally. Ms. Kline was also an economist at The World Bank Group, where she supported Ministries of Finance in emerging markets to implement technology development projects in South America, Africa, Asia, and Eastern Europe. Ms. Kline is one of the first Thai women selected to lecture a popular MBA course Impact Venture Capital Investing – Sustainable & Impact Finance Curriculum – at the Haas School of Business, UC Berkeley. She also serves Berkeley Skydeck, a top accelerator program, as an investor and Global Ambassador to 48 countries in the Asia-Pacific region. Her board work includes AHEAD Medicine (biotech), The Circulate Initiative by Circulate Capital (climate tech), Dietz Co. (health tech), and Intel Alumni Network (global tech executives). She is also an advisor to selected founders/CEOs at The Alchemist Accelerator and UCSF Health Hub Incubation in the San Francisco Bay Area.
< Back